4-(NITROOXY)BUTYL (2S)-2-(6-METHOXY-2-NAPHTHYL)PROPANOATE

Independent reference data for 4-(NITROOXY)BUTYL (2S)-2-(6-METHOXY-2-NAPHTHYL)PROPANOATE (CAS 163133-43-5), compiled from public chemistry databases.

Registry identifiers across databases

Computed descriptors

Documented uses on record

Investigated for use/treatment in pain (acute or chronic), inflammatory disorders (unspecified), osteoarthritis, and arthritis and arthritic pain.A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81)

Synonyms and trade names

Naproxcinod; 163133-43-5; Nitronaproxen; AZD3582; naproxen-n-butyl nitrate; HCT 3012; NO-naproxen; AZD-3582; HCT-3012; AR-P900758XX; AZD 3582; naproxcinodum; V24GR4LI3I; 4-(Nitrooxy)butyl (2S)-2-(6-methoxynaphthalen-2-yl)propanoate; HCT3012; (S)-2-(6-Methoxy-2-naphthyl)propanoic acid 4-nitrooxybutyl ester

GHS hazard classification

Reported hazard statements	H302 (100%), H373 (100%), H400 (100%), H410 (100%)

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

H373 (100%): May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]

What the public record says

4-(NITROOXY)BUTYL (2S)-2-(6-METHOXY-2-NAPHTHYL)PROPANOATE · CAS 163133-43-5 · C18H21NO6. UNII V24GR4LI3I.

Source: PubChem / Wikidata; the batch COA governs where values differ.